These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31156470)

  • 21. Impact of experimentally induced positive and anxious mood on alcohol expectancy strength in internally motivated drinkers.
    Grant VV; Stewart SH
    Cogn Behav Ther; 2007; 36(2):102-11. PubMed ID: 17530496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative expected value of drugs versus competing rewards underpins vulnerability to and recovery from addiction.
    Hogarth L; Field M
    Behav Brain Res; 2020 Sep; 394():112815. PubMed ID: 32707138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incubation of Methamphetamine but not Heroin Craving After Voluntary Abstinence in Male and Female Rats.
    Venniro M; Zhang M; Shaham Y; Caprioli D
    Neuropsychopharmacology; 2017 Apr; 42(5):1126-1135. PubMed ID: 28025975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysregulated responses to emotions among abstinent heroin users: correlation with childhood neglect and addiction severity.
    Gerra G; Somaini L; Manfredini M; Raggi MA; Saracino MA; Amore M; Leonardi C; Cortese E; Donnini C
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():220-8. PubMed ID: 24161666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between placebo alcohol and affect: motives for drinking.
    Bailey RC; Baillie AJ
    Drug Alcohol Rev; 2013 Mar; 32(2):162-9. PubMed ID: 22994550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of incentives for naltrexone adherence on opiate abstinence in heroin-dependent adults.
    Jarvis BP; Holtyn AF; DeFulio A; Dunn KE; Everly JJ; Leoutsakos JS; Umbricht A; Fingerhood M; Bigelow GE; Silverman K
    Addiction; 2017 May; 112(5):830-837. PubMed ID: 27936293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heroin craving and its correlations with clinical outcome indicators in people with heroin dependence receiving methadone maintenance treatment.
    Yen CF; Lin HC; Wang PW; Ko CH; Lee KH; Hsu CY; Chung KS; Wu HC; Cheng CP
    Compr Psychiatry; 2016 Feb; 65():50-6. PubMed ID: 26773990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brief Negative Affect Focused Functional Imagery Training Abolishes Stress-Induced Alcohol Choice in Hazardous Student Drinkers.
    Bakou AE; Shuai R; Hogarth L
    J Addict; 2021; 2021():5801781. PubMed ID: 34580617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gender and stimulus difference in cue-induced responses in abstinent heroin users.
    Yu J; Zhang S; Epstein DH; Fang Y; Shi J; Qin H; Yao S; Le Foll B; Lu L
    Pharmacol Biochem Behav; 2007 Mar; 86(3):485-92. PubMed ID: 17306353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coping-anxiety and coping-depression motives predict different daily mood-drinking relationships.
    Grant VV; Stewart SH; Mohr CD
    Psychol Addict Behav; 2009 Jun; 23(2):226-37. PubMed ID: 19586139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heroin self-administration in dependent Wistar rats: increased sensitivity to naloxone.
    Carrera MR; Schulteis G; Koob GF
    Psychopharmacology (Berl); 1999 May; 144(2):111-20. PubMed ID: 10394991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relation between social desirability and different measures of heroin craving.
    Marissen MA; Franken IH; Blanken P; Hendriks VM; van den Brink W
    J Addict Dis; 2005; 24(4):91-103. PubMed ID: 16368659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heroin refusal self-efficacy and preference for medication-assisted treatment after inpatient detoxification.
    Kenney SR; Bailey GL; Anderson BJ; Stein MD
    Addict Behav; 2017 Oct; 73():124-128. PubMed ID: 28505487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Additional methadone increases craving for heroin: a double-blind, placebo-controlled study of chronic opiate users receiving methadone substitution treatment.
    Curran HV; Bolton J; Wanigaratne S; Smyth C
    Addiction; 1999 May; 94(5):665-74. PubMed ID: 10563031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coping style and ecstasy use motives as predictors of current mood symptoms in ecstasy users.
    Scott RM; Hides L; Allen JS; Lubman DI
    Addict Behav; 2013 Oct; 38(10):2465-72. PubMed ID: 23770644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decision making of individuals with heroin addiction receiving opioid maintenance treatment compared to early abstinent users.
    Kriegler J; Wegener S; Richter F; Scherbaum N; Brand M; Wegmann E
    Drug Alcohol Depend; 2019 Dec; 205():107593. PubMed ID: 31634665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The polymorphism of dopamine D2 receptor TaqIA gene is associated with brain response to drug cues in male heroin-dependent individuals during methadone maintenance treatment.
    Li Y; Li Q; Li W; Chen J; Hu F; Liu Y; Wei X; Zhu J; Liu J; Ye J; Shi H; Wang Y; Wang W
    Drug Alcohol Depend; 2019 May; 198():150-157. PubMed ID: 30928885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-administration of cocaine, cannabis and heroin in the human laboratory: benefits and pitfalls.
    Haney M
    Addict Biol; 2009 Jan; 14(1):9-21. PubMed ID: 18855806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Craving and drug reward: a comparison of methadone and clonidine in detoxifying opiate addicts.
    Dawe S; Gray JA
    Drug Alcohol Depend; 1995 Oct; 39(3):207-12. PubMed ID: 8556969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mood and neuroendocrine response to a chemical stressor, metyrapone, in buprenorphine-maintained heroin dependence.
    Kakko J; von Wachenfeldt J; Svanborg KD; Lidström J; Barr CS; Heilig M
    Biol Psychiatry; 2008 Jan; 63(2):172-7. PubMed ID: 17850768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.